Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LEGNLegend Biotech | $7.87bn | n/a | n/a |
ASNDAscendis Pharma A/S | $7.77bn | n/a | n/a |
CERECerevel Therapeutics Holdings | $7.69bn | n/a | n/a |
PCVXVaxcyte | $7.09bn | n/a | n/a |
BPMCBlueprint Medicines | $6.68bn | n/a | n/a |
RETAReata Pharmaceuticals | $6.52bn | n/a | n/a |
CYTKCytokinetics | $6.49bn | n/a | n/a |
EXELExelixis | $6.22bn | 29.35 | n/a |
RVMDRevolution Medicines | $6.15bn | n/a | n/a |
IONSIonis Pharmaceuticals | $5.70bn | n/a | n/a |
ISEEIVERIC bio | $5.51bn | n/a | n/a |
IBRXImmunitybio | $5.50bn | n/a | n/a |
HALOHalozyme Therapeutics | $5.49bn | 17.74 | n/a |
SYNHSyneos Health | $4.46bn | 28.55 | n/a |
KRYSKrystal Biotech | $4.42bn | n/a | n/a |
MDGLMadrigal Pharmaceuticals | $4.37bn | n/a | n/a |
CRSPCrispr Therapeutics AG | $4.35bn | n/a | n/a |
IMVTImmunovant | $4.27bn | n/a | n/a |
ALPNAlpine Immune Sciences | $4.26bn | n/a | n/a |
NUVLNuvalent | $4.23bn | n/a | n/a |